Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in ...
Professor Yu Li and the team combine embolization and resection in a single procedure for safer outcomes in hypervascular CNS tumors. Hypervascular tumors of the central nervous system (CNS), ...
Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel ...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from ...
TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients ...
Hypervascular tumors of the brain and spinal cord pose serious challenges for neurosurgeons due to their dense blood vessel networks, which can lead to heavy bleeding and increased surgical risk. In a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback